PROCEPT BioRobotics Corp (PRCT)
93.60
-0.85
(-0.90%)
USD |
NASDAQ |
Nov 22, 16:00
95.78
+2.18
(+2.33%)
After-Hours: 20:00
PROCEPT BioRobotics Cash from Investing (Quarterly): -0.246M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -0.246M |
| June 30, 2024 | -1.043M |
| March 31, 2024 | -1.946M |
| December 31, 2023 | -8.715M |
| September 30, 2023 | -5.78M |
| June 30, 2023 | -5.372M |
| March 31, 2023 | -5.339M |
| December 31, 2022 | -0.866M |
| Date | Value |
|---|---|
| September 30, 2022 | -1.514M |
| June 30, 2022 | -0.218M |
| March 31, 2022 | -0.055M |
| December 31, 2021 | -0.332M |
| September 30, 2021 | -0.111M |
| June 30, 2021 | -0.11M |
| March 31, 2021 | -0.039M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-8.715M
Minimum
Dec 2023
-0.039M
Maximum
Mar 2021
-2.112M
Average
-0.866M
Median
Dec 2022
Cash from Investing (Quarterly) Benchmarks
| Boston Scientific Corp | -1.427B |
| Intuitive Surgical Inc | -1.413B |
| Teleflex Inc | -21.23M |
| RxSight Inc | -9.26M |
| Perspective Therapeutics Inc | -29.74M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -18.80M |
| Cash from Financing (Quarterly) | 1.715M |
| Free Cash Flow | -103.56M |
| Free Cash Flow Per Share (Quarterly) | -0.3662 |
| Free Cash Flow to Equity (Quarterly) | -19.08M |
| Free Cash Flow Yield | -2.16% |